Vaisala reports its Q3 earnings on 27th of October.
Sales -3% and adj. EBIT +2% vs. consensus Stronger than expected FCF on SEK 7m WC release Outlook un...
Redeye saw a sales performance that again was weak and thus did not meet our expectations, although ...
Redeye updates its estimates and valuation following Vitec releasing its Q3 2023 report.
Sales and EBIT up from Q2 low, reaching SEK 46m and SEK -2.
SDS publicerade den 19 oktober 2023 bolagets delårsrapport för det tredje kvartalet år 2023.
Addnode will release its Q3 2023 report on 27 October at 08:30 CEST and host a conference call at 09...
Marginellt positivt underliggande resultat i Q3’23 från svag svensk byggkonjunktur BE Group rapporte...
Redeye comments on the better-indicated momentum for Carbonhand in Germany.
Redeye sees continued solid growth momentum and impressive gross margins, partly thanks to surprisin...
Redeye provides its initial take on Vitec’s Q3 2023 report, which came in roughly in line with our e...
Sales -6% and adj. EBIT SEK +0.5m vs. ABGSCe Outlook largely unchanged as the company recovers from ...
Consti reports its Q3 results on 27th of October. We expect continued good execution supported by th...
Q3e: Two Freemelt ONE deliveries, sales SEK 10.3m, up 28% y-o-y First eMELT agreement with large glo...
iZafe vinner en upphandling med Västra Götalandsregionen för tillhandahållande av omkring 2000 Dosel...
Redeye shares its preview of Sedana Medical’s Q3 2023e results, due October 26.
OrderYOYO announced on Wednesday, October 18th, the company’s performance during Q3-23 and shows a c...
Expect a great Q3e: sales SEK 44m, up 46% y-o-y; 46% EBIT margin We raise '23e-'24e EBIT 7-4% on ann...
Redeye shares its preview of BONESUPPORT’s Q3 2023e results, due October 26.
MT Højgaard announces win of Rønne harbour phases 3 and 4No order amount included in Tuesdays press ...
